Abstract submission

Abstract reviewers

All ACPE14 abstracts are subjected to author-and-institu­tion-anonymous review from multiple reviewers. Only those abstracts with the best scores are selected for oral presentation. However, because of severe limitations in time available for oral sessions, many out­standing abstracts will be presented as an ePoster.

Thanks is due to the following reviewers for their assistance with abstract review for ACPE14:

Benjamin Bates
Sri Harsha Chalasani
K. Arnold Chan FISPE
Wen-Wen Chen
Lei Chen
Chung-Yu Chen
Ju-Ling Chen
Nai-Yu Chen
Manik Chhabra
Nam-Kyong Choi
Yu-Wen Chu
Benjamin Daniels
Juliana de Oliveira Costa
Yaa-Hui Dong
Katherine Duszynski
Hideki Endo
Michael Falster
Genevieve Gabb
Tobias Gerhard
Malcolm Gillies
Natasa Gisev
Sai Krishna Gudi
Sarah Hargreaves
Fei-Yuan Hsiao
Miyuki Hsing-Chun Hsieh

Huei-Kai Huang
Sun-Young Jung
Yea-Huei Kao Yang FISPE
Gizat Kassie
Lan Kelly
Daisuke Koide
Kiyoshi Kubota FISPE
Hiraku Kumamaru
Liang Tseng Kuo
Edward Lai
Jae-Hyun Lee
Wan-Ju Annabelle Lee
Kai-Li Liaw
Tsung-Kun Lin
Fang-Ju Lin
Vincent Lo Re FISPE
Frank May FISPE
Jingping Mo
Hoa Nguyen
Shilpa Palaksha
Byung Joo Park FISPE
Jung-Won Park
Sallie Pearson
Syd Phillips

Robert Platt
Nicole Pratt
Muhammed Rashid
Annelies Robijn
Debra Rowett
Andrea Schaffer
Juny Sebastian
Soko Setoguchi FISPE
Shih-Chieh Shao
Steven Shen
Cheng-Chan Shih
Chien-Chou Su
Yi-Chia Su
Masato Takeuchi
Yoshinori Takeuchi
Shiro Tanaka
Daniel Tsai
Krishna Undela
Meng-Ting Wang
Sawaeng Watcharathanakij
Imaina Widagdo
Chun-Ting Yang
Siyan Zhan
Wei Zhou FISPE


All enquiries regarding abstracts and the submission process should be directed to the ACPE14 Program Secretariat, Expert Events.
Expert Events
PO Box 351, Hamilton Central QLD 4007 Australia
Tel: +61 7 3848 2100 | Email: acpe@expertevents.com.au

Guidelines for abstract submission

Research abstracts are eligible, whether or not their content has been presented at meetings of other scientific societies, as long as they meet the following criteria:

  • relevant to the field of pharmacoepidemiology as broadly defined
  • results have not been published (except in abstract form) either on-line or in printed full form before January 1 of the year of the meeting, and
  • results have not been presented at a previous ISPE meeting.

The first author listed for each abstract is considered to be the presenting author who will be the primary contact for all correspondence regarding the abstract.

Abstracts must be submitted in English.

Presenter Registration
All presenting authors must have registered and paid to attend the conference by Friday 26 August 2022.

Presentation Types

Oral Presentation: 15 minutes (10 minutes for presentation and 5 minutes questions).

Option 1: Presenting in-person at the conference venue, National Cheng Kung University, Tainan, Taiwan.

Option 2: Presenting via a pre-recorded video and attending virtually for audience questions. This option is for presenters who are unable to travel to attend the conference. Consideration will be given to the country and location of speakers when scheduling them in the program.

The on-site technology will allow for both in-person and virtual attendees to ask questions of the presenters. Consideration will be given to the country and location of speakers when scheduling them in the program.

The deadline for accepted oral presenters to submit their pre-recorded presentation is Friday 30 September.

ePoster Presentation:
All attendees, whether attending in-person or online, will prepare a 3-minute pre-recorded presentation with 3 slides. Pre-recorded e-Poster presentations will be available for conference delegates to view at their convenience through the conference website.

The deadline for accepted poster presenters to submit their e-Poster presentation is Friday 30 September.

Spotlight Posters:
A number of notable ePosters will be pre-selected for the Spotlight Poster Session. These poster presenters will be invited to deliver a 3-minute oral description of their work in English, followed by audience discussions moderated by a senior ISPE member. Successful presenters will be notified on Monday 5 September 2022.

Abstract submission topics:

A.  Pharmaceutical policy and administration

B.  Pharmacoepidemiology and Pharmacovigilance research methods

C.  Drug safety risk monitoring, evaluation and prevention

D.  Pharmacogenomics research and drug safety

E.  Evidence-based medicine

F.  Evidence-based pharmacy

G.  Drug utilization evaluation studies

H.  Rational drug use

I.  Pharmacoepidemiology and traditional medicines

J.  Prevention of medication errors and drug misuse/abuse

K.  Rare disease and orphan medicines

L.  Post-marketing drug effectiveness and safety evaluation

M.  Prevention and treatment of drug-induced diseases

N.  Other related fields

Abstract format

Abstract title: must not exceed 20 words.

Abstract text: must not exceed 300 words (excluding the Title, Authors, and Affiliations).

Do not reference institution names, locations, or funding sources in the abstract.

Abstracts should include the following headings:
Keywords: list not more than four keywords describing your research.

Graphics and tables cannot be submitted as part of your abstract.

Author names and affiliations:

Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.

Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.

Abstracts which are not correctly formatted will not be reviewed.

Abstract review process

All submitted abstracts will be reviewed by at least 3 reviewers.

In evaluating each abstract, reviewers will be unaware of authors or institutions involved with the work described in the abstract. (Abstracts will be suitably anonymised by the program secretariat before being sent out to reviewers).

The Program Committee will assign accepted abstracts either to oral or poster presentation, and the reviewers’ decision is final.

Notification of Acceptance

The Organising Committee reserves the right to accept or decline any submissions and to select the presentation format.

Presenting authors will be notified of their acceptance status on Friday 15 July 2022 and must inform any co-author(s).

Presenter Registration
All presenting authors must have registered and paid to attend the conference by Friday 26 August 2022.

Accepted abstracts will be published in the conference program only if the presenting author has registered for the conference